Literature DB >> 27424290

More to Life than NF-κB in TNFR1 Signaling.

Adrian T Ting1, Mathieu J M Bertrand2.   

Abstract

TNF is a master proinflammatory cytokine whose pathogenic role in inflammatory disorders has long been attributed to induction of proinflammatory mediators. TNF also activates cell survival and death pathways, and recent studies demonstrated that TNF also causes inflammation by inducing cell death. The default response of most cells to TNF is survival and NF-κB-mediated upregulation of prosurvival molecules is a well-documented protective mechanism downstream of TNFR1. Recent studies revealed the existence of an NF-κB-independent cell death checkpoint that restricts cell demise by inactivating RIPK1. Disruption of this checkpoint leads to RIPK1 kinase-dependent death and causes inflammation in vivo. These revelations bring complexity to the control of TNF-induced cell death, and suggest clinical benefit of RIPK1 inhibitors in TNF-driven human inflammatory disorders.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27424290      PMCID: PMC5076853          DOI: 10.1016/j.it.2016.06.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  78 in total

1.  Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.

Authors:  Eugene Varfolomeev; Tatiana Goncharov; Heather Maecker; Kerry Zobel; László G Kömüves; Kurt Deshayes; Domagoj Vucic
Journal:  Sci Signal       Date:  2012-03-20       Impact factor: 8.192

2.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

3.  IAPs limit activation of RIP kinases by TNF receptor 1 during development.

Authors:  Maryline Moulin; Holly Anderton; Anne K Voss; Tim Thomas; Wendy Wei-Lynn Wong; Aleksandra Bankovacki; Rebecca Feltham; Diep Chau; Wendy D Cook; John Silke; David L Vaux
Journal:  EMBO J       Date:  2012-02-10       Impact factor: 11.598

4.  Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.

Authors:  Sean L Petersen; Lai Wang; Asligul Yalcin-Chin; Lin Li; Michael Peyton; John Minna; Patrick Harran; Xiaodong Wang
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

5.  Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD.

Authors:  Ato Wright; William W Reiley; Mikyoung Chang; Wei Jin; Andrew Joon Lee; Minying Zhang; Shao-Cong Sun
Journal:  Dev Cell       Date:  2007-11       Impact factor: 12.270

6.  The deubiquitinase activity of A20 is dispensable for NF-κB signaling.

Authors:  Arnab De; Teruki Dainichi; Chozha Vendan Rathinam; Sankar Ghosh
Journal:  EMBO Rep       Date:  2014-05-30       Impact factor: 8.807

7.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

8.  NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.

Authors:  L Boutaffala; M J M Bertrand; C Remouchamps; G Seleznik; F Reisinger; M Janas; C Bénézech; M T Fernandes; S Marchetti; F Mair; C Ganeff; A Hupalowska; J-E Ricci; B Becher; J Piette; P Knolle; J Caamano; P Vandenabeele; M Heikenwalder; E Dejardin
Journal:  Cell Death Differ       Date:  2015-06-05       Impact factor: 15.828

9.  OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.

Authors:  Tycho E T Mevissen; Manuela K Hospenthal; Paul P Geurink; Paul R Elliott; Masato Akutsu; Nadia Arnaudo; Reggy Ekkebus; Yogesh Kulathu; Tobias Wauer; Farid El Oualid; Stefan M V Freund; Huib Ovaa; David Komander
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

10.  Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis.

Authors:  Snehlata Kumari; Younes Redouane; Jaime Lopez-Mosqueda; Ryoko Shiraishi; Malgorzata Romanowska; Stefan Lutzmayer; Jan Kuiper; Conception Martinez; Ivan Dikic; Manolis Pasparakis; Fumiyo Ikeda
Journal:  Elife       Date:  2014-12-02       Impact factor: 8.140

View more
  74 in total

1.  Inhibition of protein kinase C beta phosphorylation activates nuclear factor-kappa B and improves postischemic recovery in type 1 diabetes.

Authors:  Satyanarayana Alleboina; Thomas Wong; Madhu V Singh; Ayotunde O Dokun
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

Review 2.  Tumor necrosis factor-driven cell death in donor organ as a barrier to immunological tolerance.

Authors:  Rosalind L Ang; Adrian T Ting
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

3.  Antioxidant and immunomodulatory activity induced by stevioside in liver damage: In vivo, in vitro and in silico assays.

Authors:  Sael Casas-Grajales; Erika Ramos-Tovar; Esmeralda Chávez-Estrada; Diana Alvarez-Suarez; Erika Hernández-Aquino; Karina Reyes-Gordillo; Carlos M Cerda-García-Rojas; Javier Camacho; Víctor Tsutsumi; M Raj Lakshman; Pablo Muriel
Journal:  Life Sci       Date:  2019-03-16       Impact factor: 5.037

Review 4.  Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease.

Authors:  Holly Anderton; Ian P Wicks; John Silke
Journal:  Nat Rev Rheumatol       Date:  2020-07-08       Impact factor: 20.543

5.  When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157.

Authors:  Diego Rojas-Rivera; Tinneke Delvaeye; Ria Roelandt; Wim Nerinckx; Koen Augustyns; Peter Vandenabeele; Mathieu J M Bertrand
Journal:  Cell Death Differ       Date:  2017-04-28       Impact factor: 15.828

6.  Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis.

Authors:  Palak Amin; Marcus Florez; Ayaz Najafov; Heling Pan; Jiefei Geng; Dimitry Ofengeim; Slawomir A Dziedzic; Huibing Wang; Vica Jean Barrett; Yasushi Ito; Matthew J LaVoie; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-11       Impact factor: 11.205

7.  Caspases in Cell Death, Inflammation, and Pyroptosis.

Authors:  Sannula Kesavardhana; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Annu Rev Immunol       Date:  2020-02-04       Impact factor: 28.527

8.  Inhibition of TNFR1 Attenuates LPS Induced Apoptosis and Inflammation in Human Nucleus Pulposus Cells by Regulating the NF-KB and MAPK Signalling Pathway.

Authors:  Feng Lv; Longbiao Yang; Jianxiu Wang; Zhixiang Chen; Qizhao Sun; Peiguo Zhang; Chentong Guan; Yanbin Liu
Journal:  Neurochem Res       Date:  2021-03-13       Impact factor: 3.996

Review 9.  Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics.

Authors:  Abhishek D Garg; Sanket More; Nicole Rufo; Odeta Mece; Maria Livia Sassano; Patrizia Agostinis; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-10-04       Impact factor: 8.110

10.  Molluscum Contagiosum Virus MC159 Abrogates cIAP1-NEMO Interactions and Inhibits NEMO Polyubiquitination.

Authors:  Sunetra Biswas; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.